Screening Eligibility and Survival Among Patients With Lung Cancer in Korea - Top-Institutions - MDSpire

Assessment of Screening Criteria and Prognosis in Lung Cancer Patients in South Korea

  • By

  • Yeon Wook Kim

  • Tae Ho Yoon

  • Kyeong Im Kwak

  • Minji Han

  • Eung Joo Park

  • Choon-Taek Lee

  • July 21, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Seoul National University Bundang Hospital
    Seoul National University Bundang Hospital

    Seongnam, Gyeonggi-do

    Key Differentiators

    • Oncology

  • #2

    Korea-Clinical Data Utilization Network for Research Excellence (K-CURE)
    Korea-Clinical Data Utilization Network for Research Excellence (K-CURE)

    Seoul, Seoul

    Key Differentiators

    • Oncology

  • #3

    National Lung Screening Trial
    National Lung Screening Trial

    Bethesda, Maryland

    Key Differentiators

    • Oncology

  • #4

    Osaka University Hospital
    Osaka University Hospital

    Osaka, Osaka

    Key Differentiators

    • Oncology

Original Source(s)

Screening Eligibility and Survival Among Patients With Lung Cancer in Korea

  • by Yeon Wook Kim, Tae Ho Yoon, Kyeong Im Kwak, Minji Han, Eung Joo Park, Choon-Taek Lee

  • July 21, 2026

Related Content

Critical complications in cancer patients admitted to the ICU in the era of immunotherapy: recognition, differential diagnosis, and management

Expression and prognostic significance of INSM1 compared with traditional neuroendocrine markers in mixed urothelial and small-cell carcinoma of the renal pelvis

Editorial: Navigating the landscape of IDH-mutant gliomas: advances in diagnosis, therapeutic management, and long-term monitoring